CIRB Studies
Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number | Lead Group | Study Title | CIRB | Study Status |
|---|---|---|---|---|
| UWI2014-03-01 | CP-CTNet_CLO-University of Wisconsin | A Phase I Trial of the Safety and Immunogenicity of a DNA Plasmid Based Vaccine (WOKVAC) Encoding Epitopes Derived from Three Breast Cancer Antigens (IGFBP-2, HER2, AND IGF-1R) in Patients with Breast Cancer | Cancer Prevention and Control CIRB | Available to Open |
| UWI2016-07-01 | CP-CTNet_CLO-University of Wisconsin | Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment | Cancer Prevention and Control CIRB | Completed |
| NWU2016-08-02 | CLO-Northwestern University | A Phase I Single-Arm, Multicenter Pilot Study Aimed at Validating Gamma-OHPdG as a Biomarker and Testing the Effects of Polyphenon E® on its Levels in Patients with Cirrhosis | Cancer Prevention and Control CIRB | Available to Open |
| WF-2201 | NCORP-Wake Forest University | Hypofractionated Radiotherapy vs Single Fraction Radiosurgery for Brain Metastasis Patients on Immunotherapy (HYPOGRYPHE) | Cancer Prevention and Control CIRB | Available to Open |
| A231701CD | Alliance | Increasing Socioeconomically Disadvantaged Patients’ Engagement in Breast Cancer Surgery Decision Making Through a Shared Decision Making Intervention | Cancer Prevention and Control CIRB | Available to Open |
| NWU20-02-02 | CLO-Northwestern University | A Randomized and Placebo-Controlled Phase II Trial Targeting Dominant-Negative Missense Mutant P53 By Atorvastatin for Reducing the Risk of Longstanding Ulcerative Colitis-Associated Cancer | Cancer Prevention and Control CIRB | Available to Open |
| A221602 | Alliance | Olanzapine with or without fosaprepitant for the prevention of chemotherapy induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial | Cancer Prevention and Control CIRB | Available to Open |
| URCC-18007 | NCORP-University of Rochester Cancer Center | Randomized Placebo-Controlled Trial of Bupropion for Cancer-Related Fatigue | Cancer Prevention and Control CIRB | Available to Open |
| WF-1901 | NCORP-Wake Forest University | Internet-delivered Management of Pain Among Cancer Treatment Survivors (IMPACTS) | Cancer Prevention and Control CIRB | Available to Open |
| MDA2014-04-01 | CP-CTNet_CLO-MD Anderson | Alternative Dosing of Exemestane in Postmenopausal Women with Stage 0-II ER-Positive Breast Cancer: a Randomized Presurgical Trial | Cancer Prevention and Control CIRB | Completed |